{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:16:13Z","timestamp":1787670973028,"version":"build-2736575974"},"reference-count":35,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,30]]},"DOI":"10.20945\/2359-3997000000227","type":"journal-article","created":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T13:38:40Z","timestamp":1586353120000},"source":"Crossref","is-referenced-by-count":5,"title":["Decreased serum levels of IL-27and IL-35 in patients with Graves disease"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5883-6922","authenticated-orcid":false,"given":"Malek-Hosseini","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-9449","authenticated-orcid":false,"given":"Kalantar","family":"Kurosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1027-7906","authenticated-orcid":false,"given":"Amirghofran","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-0376","authenticated-orcid":false,"given":"Dabbaghmanesh Mohamad","family":"Hossein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-1984","authenticated-orcid":false,"given":"Rostamzadeh","family":"Davood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-4736","authenticated-orcid":false,"given":"Mohammad Reza","family":"Ataollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"key":"key20200408093837_B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-4407-4","volume-title":"Graves\u2019 Disease: Pathogenesis and Treatment","author":"Rapoport","year":"2000","unstructured":".Rapoport B, McLachlan SM. Graves\u2019 Disease: Pathogenesis and Treatment. Berlin: Springer Science & Business Media; 2000."},{"key":"key20200408093837_B2","first-page":"43","article-title":"Signs and symptoms of thyroid dysfunction","author":"Karnath","year":"2006","unstructured":".Karnath BM, Hussain N. Signs and symptoms of thyroid dysfunction. Hospital Physician. 2006:43-8.","journal-title":"Hospital Physician"},{"issue":"24","key":"key20200408093837_B3","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Graves\u2019 disease","volume":"358","author":"Brent","year":"2008","unstructured":".Brent GA. Graves\u2019 disease. N Engl J Med. 2008;358(24):2594-605.","journal-title":"N Engl J Med"},{"issue":"4","key":"key20200408093837_B4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/09674845.2007.11732781","article-title":"Levels of cytokines and thyroid autoantibodies in Omani patients with Graves\u2019 disease","volume":"64","author":"Alnaqdy","year":"2007","unstructured":".Alnaqdy A, Al-Maskari M. Levels of cytokines and thyroid autoantibodies in Omani patients with Graves\u2019 disease. Br J Biomed Sci. 2007;64(4):164-7.","journal-title":"Br J Biomed Sci"},{"issue":"3","key":"key20200408093837_B5","first-page":"481","article-title":"Cytokines and Graves\u2019 disease","volume":"11","author":"Weetman","year":"1997","unstructured":".Weetman A, Ajjan RA, Watson P. Cytokines and Graves\u2019 disease. Best Pract Res Clin Endocrinol Metab. 1997;11(3):481-97.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20200408093837_B6","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/609593","article-title":"Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy","volume":"2015","author":"Shen","year":"2015","unstructured":".Shen J, Li Z, Li W, Ge Y, Xie M, Lv M,  et al. Th1, Th2, and Th17 cytokine involvement in thyroid associated ophthalmopathy. Dis Markers. 2015;2015:609593.","journal-title":"Dis Markers"},{"issue":"9","key":"key20200408093837_B7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/thy.2007.0405","article-title":"Cytokines, Graves\u2019 disease, and thyroid-associated ophthalmopathy","volume":"18","author":"Gianoukakis","year":"2008","unstructured":".Gianoukakis AG, Khadavi N, Smith TJ. Cytokines, Graves\u2019 disease, and thyroid-associated ophthalmopathy. Thyroid. 2008;18(9):953-8.","journal-title":"Thyroid"},{"issue":"10","key":"key20200408093837_B8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","unstructured":".Moudgil KD, Choubey D. Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res. 2011;31(10):695-703.","journal-title":"J Interferon Cytokine Res"},{"key":"key20200408093837_B9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-065X.2008.00710.x","article-title":"Regulation of immune responses by interleukin-27","volume":"226","author":"Yoshida","year":"2008","unstructured":".Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev. 2008;226:234-47.","journal-title":"Immunol Rev"},{"key":"key20200408093837_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394299-9.00001-1","article-title":"The immunobiology of IL-27","volume":"115","author":"Hall","year":"2012","unstructured":".Hall AOH, Silver JS, Hunter CA. The immunobiology of IL-27 Adv Immunol. 2012;115:1-44.","journal-title":"Adv Immunol"},{"issue":"1","key":"key20200408093837_B11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/eji.201040804","article-title":"IL\u201027 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells","volume":"41","author":"Schneider","year":"2011","unstructured":".Schneider R, Yaneva T, Beauseigle D, El\u2010Khoury L, Arbour N. IL\u201027 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur J Immunol. 2011;41(1):47-59.","journal-title":"Eur J Immunol"},{"issue":"11","key":"key20200408093837_B12","doi-asserted-by":"crossref","first-page":"7579","DOI":"10.4049\/jimmunol.177.11.7579","article-title":"IL-27 induces Th1 differentiation via p38 MAPK\/T-bet-and intercellular adhesion molecule-1\/LFA-1\/ERK1\/2-dependent pathways","volume":"177","author":"Owaki","year":"2006","unstructured":".Owaki T, Asakawa M, Fukai F, Mizuguchi J, Yoshimoto T. IL-27 induces Th1 differentiation via p38 MAPK\/T-bet-and intercellular adhesion molecule-1\/LFA-1\/ERK1\/2-dependent pathways. J Immunol. 2006;177(11):7579-87.","journal-title":"J Immunol"},{"issue":"2","key":"key20200408093837_B13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4049\/jimmunol.173.2.715","article-title":"Understanding the pro-and anti-inflammatory properties of IL-27","volume":"173","author":"Villarino","year":"2004","unstructured":".Villarino AV, Huang E, Hunter CA. Understanding the pro-and anti-inflammatory properties of IL-27. J Immunol. 2004;173(2):715-20.","journal-title":"J Immunol"},{"key":"key20200408093837_B14","article-title":"IL-35 Is a Novel Responsive Anti-Inflammatory Cytokine-A New System of Categorizing Anti-Inflammatory Cytokines","author":"Yang","year":"2012","unstructured":".Yang XF, Li X, Mai J, Virtue A, Yin Y, Sha X,  et al. IL-35 Is a Novel Responsive Anti-Inflammatory Cytokine-A New System of Categorizing Anti-Inflammatory Cytokines. Am Soc Hematol. 2012.","journal-title":"Am Soc Hematol"},{"issue":"3","key":"key20200408093837_B15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033628","article-title":"IL-35 is a novel responsive anti-inflammatory cytokine \u2013 a new system of categorizing anti-inflammatory cytokines","volume":"7","author":"Li","year":"2012","unstructured":".Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X,  et al. IL-35 is a novel responsive anti-inflammatory cytokine \u2013 a new system of categorizing anti-inflammatory cytokines. PloS One. 2012;7(3):e33628.","journal-title":"PloS One"},{"issue":"3","key":"key20200408093837_B16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12016-015-8468-9","article-title":"IL-35 and autoimmunity: a comprehensive perspective","volume":"49","author":"Choi","year":"2015","unstructured":".Choi J, Leung PS, Bowlus C, Gershwin ME. IL-35 and autoimmunity: a comprehensive perspective. Clin Rev Allergy Immunol. 2015;49(3):327-32.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"key20200408093837_B17","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.4238\/2011.October.31.6","article-title":"Association between interleukin 21 and Graves\u2019 disease","volume":"10","author":"Jia","year":"2011","unstructured":".Jia H, Zhang Z, Gu X, Guo T, Cui B, Ning G,  et al. Association between interleukin 21 and Graves\u2019 disease. Genet Mol Res. 2011;10(4):3338-46.","journal-title":"Genet Mol Res"},{"key":"key20200408093837_B18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00521","article-title":"Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases","volume":"8","author":"Fr\u00f6hlich","year":"2017","unstructured":".Fr\u00f6hlich E, Wahl RJ. Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 2017;8:521.","journal-title":"Front Immunol"},{"issue":"3","key":"key20200408093837_B19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/S0004-27302011000300002","article-title":"Ultrasonography compared to magnetic resonance imaging in thyroid-associated Graves\u2019 ophthalmopathy","volume":"55","author":"Vlainich","year":"2011","unstructured":".Vlainich AR, Romaldini JH, Pedro AB, Farah CS, Sinisgalli Jr CA. Ultrasonography compared to magnetic resonance imaging in thyroid-associated Graves\u2019 ophthalmopathy. Arq Bras Endocrinol Metab. 2011;55(3):184-8.","journal-title":"Arq Bras Endocrinol Metab"},{"issue":"6","key":"key20200408093837_B20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.seminoncol.2012.10.001","article-title":"Immune tolerance and transplantation","volume":"39","author":"Alpdogan","year":"2012","unstructured":".Alpdogan O, van den Brink MR, editors. Immune tolerance and transplantation. Semin Oncol. 2012;39(6):629-42.","journal-title":"Semin Oncol"},{"issue":"1","key":"key20200408093837_B21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1210\/en.2006-0736","article-title":"Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts","volume":"148","author":"Gianoukakis","year":"2007","unstructured":".Gianoukakis AG, Jennings TA, King CS, Sheehan CE, Hoa N, Heldin P,  et al. Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology. 2007;148(1):54-62.","journal-title":"Endocrinology"},{"issue":"1","key":"key20200408093837_B22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187152809787582507","article-title":"The IL-12 family of cytokines in infection, inflammation and autoimmune disorders","volume":"8","author":"Gee","year":"2009","unstructured":".Gee K, Guzzo C, Mat C, Nor F, Ma W, Kumar AJI,  et al. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009;8(1):40-52.","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"8","key":"key20200408093837_B23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","unstructured":".Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722-8.","journal-title":"Nat Immunol"},{"issue":"6","key":"key20200408093837_B24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2012.11.003","article-title":"Fifteen years of interleukin-27-discovery, advances and translation","volume":"37","author":"Hunter","year":"2012","unstructured":".Hunter C, Kastelein R. Fifteen years of interleukin-27-discovery, advances and translation. Immunity. 2012;37(6):960-9.","journal-title":"Immunity"},{"issue":"11","key":"key20200408093837_B25","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21111565","article-title":"Circulating IL-27 is elevated in rheumatoid arthritis patients","volume":"21","author":"Lai","year":"2016","unstructured":".Lai X, Wang H, Cao J, Li Y, Dai Y, Xiang Y,  et al. Circulating IL-27 is elevated in rheumatoid arthritis patients. Molecules. 2016;21(11). pii: E1565.","journal-title":"Molecules"},{"issue":"10","key":"key20200408093837_B26","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.176.10.5890","article-title":"Differential effects of IL-27 on human B cell subsets","volume":"176","author":"Larousserie","year":"2006","unstructured":".Larousserie F, Charlot P, Bardel E, Froger J, Kastelein RA, Devergne O. Differential effects of IL-27 on human B cell subsets. J Immunol. 2006;176(10):5890-7.","journal-title":"J Immunol"},{"issue":"9","key":"key20200408093837_B27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","unstructured":".Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S,  et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol. 2006;7(9):929-36.","journal-title":"Nat Immunol"},{"issue":"6","key":"key20200408093837_B28","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4049\/jimmunol.173.6.3871","article-title":"An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells","volume":"173","author":"Kamiya","year":"2004","unstructured":".Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol. 2004;173(6):3871-7.","journal-title":"J Immunol"},{"issue":"6","key":"key20200408093837_B29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00005-010-0098-6","article-title":"Interleukin-27: biological properties and clinical application","volume":"58","author":"Jankowski","year":"2010","unstructured":".Jankowski M, Kopin8ski P, Goc A. Interleukin-27: biological properties and clinical application. Arch Immunol Ther Exp (Warsz). 2010;58(6):417-25.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"key20200408093837_B30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.imlet.2008.01.011","article-title":"Advances in understanding the anti-inflammatory properties of IL-27","volume":"117","author":"Stumhofer","year":"2008","unstructured":".Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett. 2008;117(2):123-30.","journal-title":"Immunol Lett"},{"issue":"12","key":"key20200408093837_B31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","unstructured":".Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J,  et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol. 2010;11(12):1093-101.","journal-title":"Nat Immunol"},{"key":"key20200408093837_B32","doi-asserted-by":"crossref","DOI":"10.1186\/s12950-017-0164-5","article-title":"Interleukin-35 on B cell and T cell induction and regulation","volume":"14","author":"Huang","year":"2017","unstructured":".Huang A, Cheng L, He M, Nie J, Wang J, Jiang K. Interleukin-35 on B cell and T cell induction and regulation. J Inflamm (Lond). 2017;14:16.","journal-title":"J Inflamm (Lond)"},{"key":"key20200408093837_B33","doi-asserted-by":"crossref","DOI":"10.1038\/srep12633","article-title":"Interleukin-35 administration counteracts established murine type 1 diabetes \u2013 possible involvement of regulatory T cells","volume":"5","author":"Singh","year":"2015","unstructured":".Singh K, Kadesj\u00f6 E, Lindroos J, Hjort M, Lundberg M, Espes D,  et al. Interleukin-35 administration counteracts established murine type 1 diabetes \u2013 possible involvement of regulatory T cells. Sci Rep. 2015;5:12633.","journal-title":"Sci Rep"},{"issue":"11","key":"key20200408093837_B34","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/eji.200737810","article-title":"IL\u201035 is a novel cytokine with therapeutic effects against collagen\u2010induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells","volume":"37","author":"Niedbala","year":"2007","unstructured":".Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB,  et al. IL\u201035 is a novel cytokine with therapeutic effects against collagen\u2010induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol. 2007;37(11):3021-9.","journal-title":"Eur J Immunol"},{"issue":"12","key":"key20200408093837_B35","first-page":"1809","article-title":"Role of Treg\/Th17 cells and related cytokines in Graves\u2019 ophthalmopathy","volume":"34","author":"Lv","year":"2014","unstructured":".Lv M, Shen J, Li Z, Zhao D, Chen Z, Wan H,  et al. Role of Treg\/Th17 cells and related cytokines in Graves\u2019 ophthalmopathy. Nan Fang Yi Ke Da Xue Bao. 2014;34(12):1809-13.","journal-title":"Nan Fang Yi Ke Da Xue Bao"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T13:39:00Z","timestamp":1586353140000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005002209&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":35,"alternative-id":["10.20945\/2359-3997000000227"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000227","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]}}}